Alexion to buy Synageva in $8.4 billion biotech deal
May 06, 2015 at 07:30 AM EDT
Alexion to have eight disease treatments in clinical trials after deal.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|